Complex HBV populations with mutations in core promoter, C gene, and pre-S region are associated with development of cirrhosis in long-term renal transplant recipients

Complex HBV populations with mutations in core promoter, C gene, and pre-S region are associated with development of cirrhosis in long-term renal transplant recipients
复制标题

DOI:
10.1053/jhep.2002.30698
复制
发表时间:
2002-02-01
期刊:
影响因子:
13.5
通讯作者:
Meisel, H
Meisel, H
中科院分区:
医学1区
文献类型:
--
作者:
Preikschat, P;Günther, S;Meisel, H

文献摘要

被引文献

相似文献

慢性B型肝炎病毒(HBV)感染的长期免疫抑制肾移植受者经常发展为肝硬化(LC)和终末期肝病(ESLD)。本研究调查了这些患者中与临床病程相关的特定HBV突变体的积累和持续性(n = 38;平均随访时间为3.5年)。通过聚合酶链反应(PCR)片段的长度多态性(中位数,每例患者6.5份血清样本)以及346个全长HBV基因组的克隆和部分测序,对HBV进行纵向分析。14例患者(第1组)发生LC或死于ESLD,而24例患者(第2组)在随访期间未显示LC的证据。LC和ESLD的发生与HBV突变群体的持续存在有关,这些突变群体的特征是核心启动子缺失/插入加上C基因缺失和/或前S区缺失(第1组86% vs第2组17%; P <0.0001)。不含这些突变或仅含核心启动子突变的HBV主要见于第2组(第1组14% vs第2组75%)。在感染核心启动子突变体的患者中,C基因和/或前S区缺失的额外出现和持续存在伴随或随后发生LC和ESLD。突变以各种组合分布在单个基因组上,导致病毒群体的高度复杂性。总之,这些数据表明,积累和持续存在的特定HBV群体的突变特征在3个亚基因组区域发挥作用的发病机制,LC和ESLD在长期肾移植受者。
Long-term immunosuppressed renal transplant recipients with chronic hepatitis B virus (HBV) infection often develop liver cirrhosis (LC) and end-stage liver disease (ESLD). This study investigated accumulation and persistence of specific HBV mutants in relation to the clinical course in these patients (n = 38; mean follow-up, 3.5 years). HBV was analyzed longitudinally via length polymorphism of polymerase chain reaction (PCR) fragments (median, 6.5 serum samples per patient) as well as by cloning and partial sequencing of 346 full-length HBV genomes. Fourteen patients (group 1) developed LC or died from ESLD, whereas 24 patients (group 2) showed no evidence of LC during follow-up. Development of LC and ESLD was associated with persistence of HBV mutant populations characterized by deletions/insertions in core promoter plus deletions in the C gene and/or deletions in the pre-S region (86% of group 1 vs. 17% of group 2; P < .0001). HBV without these mutations or with core promoter mutations alone were predominantly found in group 2 (14% of group 1 vs. 75% of group 2). In patients infected with core promoter mutants, the additional appearance and persistence of deletions in the C gene and/or the pre-S region were accompanied or followed by development of LC and ESLD. The mutations were distributed on individual genomes in various combinations, leading to a high complexity of the virus population. In conclusion, these data suggest that accumulation and persistence of specific HBV populations characterized by mutations in 3 subgenomic regions play a role in pathogenesis of LC and ESLD in long-term renal transplant recipients.